LE WE PMID CA
Gene transfer994Gentransfer

Adenosine deaminase deficiency

Adenovirus

Atadenovirus

BAC YAC artificial chromosome

Biomembranes (BASKET)

Cloning (Whole organism)

DNA Vaccine

Duchenne s muscular dystrophy

Exon skipping

Eye (Pharmacology)

Gene transfer

Genetics (Transposon)

Hemoglobinopathy

Imaging (Molecular)

Immunodeficiency (Inherited)

Kidney (Neoplasm)

Laboratory animal (Pig)

Liver (Fibrosis)

MGMT

Morpholino

Nanomedicine

Neoplasia (Tumor biology and immunology)

Neurodegeneration

O6 alkylguanine DNA alkyltransferase

Oxygen (Hypoxia)

Radiation therapy

Redox (BASKET)

Regeneration of tissues and other biologic structures

RNA (MicroRNA)

RNA (Splicing)

RPE65

Splicing

Synthetic biology

Ultrasound (Toxicity and therapeutic use)

Wiskott Aldrich syndrome

Xenobiotics

1999  
1
Herpes simplex virus vectors for gene therapy in Parkinson's disease and other diseases of the nervous system.
[10703493] J R Soc Med 92(11): 566-70 (1999)
1997  
2
Optimal techniques for arterial gene transfer.
[9415283] Cardiovasc Res 35(3): 391-404 (1997)
2006  
3
Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery.
[16507881] Pharmacol Rev 58(1): 32-45 (2006)
2000  
4
Design of retroviral vectors and helper cells for gene therapy.
[11121508] Pharmacol Rev 52(4): 493-511 (2000)
2005  
5
Baculovirus as a highly efficient expression vector in insect and mammalian cells.
[15780188] Acta Pharmacol Sin 26(4): 405-16 (2005)
2009  
6
Herpes vector-mediated gene transfer in the treatment of chronic pain.
[18841093] Mol Ther 17(1): 13-8 (2009)
2008  
7
Recombinant adeno-associated virus transduction and integration.
[18500252] Mol Ther 16(7): 1189-99 (2008)
2008  
8
Gene delivery to the nervous system.
[18362921] Mol Ther 16(4): 640-6 (2008)
2007  
9
Advances in preclinical investigation of prostate cancer gene therapy.
[17457317] Mol Ther 15(6): 1053-64 (2007)
2009  
10
2008  
11
Nano-vectors for efficient liver specific gene transfer.
[18488414] Int J Nanomedicine 3(1): 31-49 (2008)
2007  
12
Virus-mediated gene transfer to induce therapeutic angiogenesis: where do we stand?
[18203421] Int J Nanomedicine 2(4): 527-40 (2007)
2007  
13
Layered double hydroxide nanoparticles as cellular delivery vectors of supercoiled plasmid DNA.
[17722544] Int J Nanomedicine 2(2): 163-74 (2007)
2000  
14
Update on adenovirus and its vectors.
[11038369] J Gen Virol 81(Pt 11): 2573-604 (2000)
1983  
15
Cloning vectors derived from animal viruses.
[6300283] J Gen Virol 64 (Pt 2)(-): 255-66 (1983)
2010  
16
Herpesvirus vectors for therapy of brain tumors.
[20811578] Open Virol J 4(-): 103-8 (2010)
2004  
17
Ovine atadenovirus: a review of its biology, biosafety profile and application as a gene delivery vector.
[15061773] Immunol Cell Biol 82(2): 189-95 (2004)
2007  
18
Potential of helper-dependent adenoviral vectors in modulating airway innate immunity.
[17484801] Cell Mol Immunol 4(2): 81-9 (2007)
2007  
19
BAC to immunology--bacterial artificial chromosome-mediated transgenesis for targeting of immune cells.
[17437533] Immunology 121(3): 308-13 (2007)
2009  
20
Use of HIV as a gene transfer vector.
[19936329] Acta Biochim Pol 56(4): 531-95 (2009)
2005  
21
Adeno-associated virus vector-mediated gene delivery to the vasculature and kidney.
[15940344] Acta Biochim Pol 52(2): 293-9 (2005)
2004  
22
Production of functional transgenic mice by DNA pronuclear microinjection.
[15094822] Acta Biochim Pol 51(1): 9-31 (2004)
2006  
23
Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
[16541123] Cell Res 16(3): 241-59 (2006)
2000  
24
Gene transfer into chicken embryos by retrovirus vectors.
[10910127] Dev Growth Differ 42(3): 213-8 (2000)
2000  
25
Application of efficient and specific gene transfer systems and organ culture techniques for the elucidation of mechanisms of epithelial-mesenchymal interaction in the developing gut.
[10910126] Dev Growth Differ 42(3): 207-11 (2000)
2009  
26
Progress and prospects: the design and production of plasmid vectors.
[19129858] Gene Ther 16(2): 165-71 (2009)
2008  
27
Manufacturing and characterizing AAV-based vectors for use in clinical studies.
[18418418] Gene Ther 15(11): 840-8 (2008)
2008  
28
AAV-mediated gene therapy for retinal disorders: from mouse to man.
[18418417] Gene Ther 15(11): 849-57 (2008)
2008  
29
Clinical gene therapy using recombinant adeno-associated virus vectors.
[18418415] Gene Ther 15(11): 858-63 (2008)
2008  
30
AAV vectors for RNA-based modulation of gene expression.
[18418414] Gene Ther 15(11): 864-9 (2008)
2008  
31
Toward exascale production of recombinant adeno-associated virus for gene transfer applications.
[18401433] Gene Ther 15(11): 823-30 (2008)
2008  
32
Potential of AAV vectors in the treatment of metabolic disease.
[18401432] Gene Ther 15(11): 831-9 (2008)
2008  
33
Adeno-associated virus integration: virus versus vector.
[18401436] Gene Ther 15(11): 817-22 (2008)
2008  
34
Strategies for manufacturing recombinant adeno-associated virus vectors for gene therapy applications exploiting baculovirus technology.
[18632744] Brief Funct Genomic Proteomic 7(4): 303-11 (2008)
2007  
35
Animal transgenesis: state of the art and applications.
[17272861] J Appl Genet 48(1): 47-61 (2007)
2007  
36
Transformation of plasmid DNA into E. coli using the heat shock method.
[18997900] J Vis Exp -(6): 253 (2007)
2006  
37
Gene-gun transfection of hippocampal neurons.
[18704184] J Vis Exp -(1): 121 (2006)
1999  
38
HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications.
[10933055] Neoplasia 1(5): 402-16 (1999)
1999  
39
HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.
[10933054] Neoplasia 1(5): 387-401 (1999)
2009  
40
Murine bone marrow-derived mesenchymal stem cells as vehicles for interleukin-12 gene delivery into Ewing sarcoma tumors.
[19051291] Cancer 115(1): 13-22 (2009)
2002  
41
2008  
42
Clinical relevance of the homologous recombination machinery in cancer therapy.
[17953711] Cancer Sci 99(2): 187-94 (2008)
2006  
43
Non-viral vectors for cancer therapy.
[16630130] Cancer Sci 97(5): 348-54 (2006)
2001  
44
Adeno-associated virus for cancer gene therapy.
[11522617] Cancer Res 61(17): 6313-21 (2001)
2005  
45
Vector-mediated cancer gene therapy: an overview.
[15908802] Cancer Biol Ther 4(5): 512-7 (2005)
2009  
46
The 'timely' development of Rexin-G: first targeted injectable gene vector (review).
[19578735] Int J Oncol 35(2): 229-38 (2009)
2006  
47
Pathotropic nanoparticles for cancer gene therapy Rexin-G IV: three-year clinical experience.
[17016635] Int J Oncol 29(5): 1053-64 (2006)
2009  
48
Armed replicating adenoviruses for cancer virotherapy.
[19197323] Cancer Gene Ther 16(6): 473-88 (2009)
2006  
49
Transductional targeting of adenovirus vectors for gene therapy.
[16439993] Cancer Gene Ther 13(9): 830-44 (2006)
2005  
50
Adeno-associated virus vectors: potential applications for cancer gene therapy.
[15962012] Cancer Gene Ther 12(12): 913-25 (2005)
2002  
51
Adenoviral vectors: systemic delivery and tumor targeting.
[12522442] Cancer Gene Ther 9(12): 1036-42 (2002)
2002  
52
Selectively replicating viral vectors.
[12522438] Cancer Gene Ther 9(12): 987-1000 (2002)
2002  
53
Intravascular adenoviral agents in cancer patients: lessons from clinical trials.
[12522437] Cancer Gene Ther 9(12): 979-86 (2002)
2002  
54
RNA viruses as virotherapy agents.
[12522435] Cancer Gene Ther 9(12): 961-6 (2002)
2002  
55
Virotherapy for cancer: current status, hurdles, and future directions.
[12522434] Cancer Gene Ther 9(12): 959-60 (2002)
2002  
56
Viruses as gene delivery vectors: application to gene function, target validation, and assay development.
[12136431] Cancer Gene Ther 9(8): 692-9 (2002)
2000  
57
Adenovirus as a gene therapy vector for hematopoietic cells.
[10880011] Cancer Gene Ther 7(6): 816-25 (2000)
1999  
58
Development and application of adenoviral vectors for gene therapy of cancer.
[10195879] Cancer Gene Ther 6(2): 113-38 (1999)
1996  
59
Keratinocyte gene transfer and gene therapy.
[8909878] Crit Rev Oral Biol Med 7(3): 204-21 (1996)
2008  
60
Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides.
[18558618] Nucleic Acids Res 36(12): 4158-71 (2008)
2000  
61
Latest developments in gene transfer technology: achievements, perspectives, and controversies over therapeutic applications.
[10661569] Stem Cells 18(1): 19-39 (2000)
1997  
62
Gene transfer into hematopoietic cells.
[9368332] Stem Cells 15 Suppl 1(-): 123-34 (1997)
2005  
63
Nonviral gene transfer to skeletal, smooth, and cardiac muscle in living animals.
[16002623] Am J Physiol Cell Physiol 289(2): C233-45 (2005)
2007  
64
The problem of passenger genes in transgenic mice.
[17690316] Arterioscler Thromb Vasc Biol 27(10): 2100-3 (2007)
1999  
65
Vascular gene transfer : from bench to bedside.
[9974398] Arterioscler Thromb Vasc Biol 19(2): 196-207 (1999)
1999  
66
Gene therapy for rheumatic diseases.
[9920008] Arthritis Rheum 42(1): 1-16 (1999)
2008  
67
Development of gene therapy for blood disorders.
[18441245] Blood 111(9): 4431-44 (2008)
1999  
68
Gene transfer by adenovectors.
[10590039] Blood 94(12): 3965-7 (1999)
1997  
69
Potential use of herpes simplex virus (HSV) vectors for gene therapy of neurological disorders.
[9236634] Brain 120 ( Pt 7)(-): 1245-59 (1997)
1997  
70
Adenoviral vectors for hepatic gene transfer in animals.
[9184566] Chest 111(6 Suppl): 138S-142S (1997)
2008  
71
Gene therapy in heart failure.
[18566312] Circ Res 102(12): 1458-70 (2008)
2006  
72
Induction of HIF-1alpha and iNOS with siRNA: a novel mechanism for myocardial protection.
[16397152] Circ Res 98(1): 10-1 (2006)
2001  
73
Assessment of risks associated with cardiovascular gene therapy in human subjects.
[11532899] Circ Res 89(5): 389-400 (2001)
2007  
74
Therapeutic gene regulation: targeting transcription.
[17353455] Circulation 115(10): 1180-3 (2007)
2006  
75
Large animal models and gene therapy.
[16333317] Eur J Hum Genet 14(3): 266-72 (2006)
2001  
76
The promise and potential hazards of adenovirus gene therapy.
[11302979] Gut 48(5): 733-6 (2001)
1997  
77
Gene delivery to the epidermis.
[9300669] Hum Mol Genet 6(10): 1761-7 (1997)
1993  
78
Transgenesis in nonmurine species.
[8406669] Hypertension 22(4): 630-3 (1993)
2000  
79
Renal transfer of genetically engineered cells.
[11065349] J Am Soc Nephrol 11 Suppl 16(-): S154-8 (2000)
2000  
80
Critical aspects of viral vectors for gene transfer into the kidney.
[11065348] J Am Soc Nephrol 11 Suppl 16(-): S149-53 (2000)
2002  
81
Gene electrotransfer: potential for gene therapy of renal diseases.
[11841610] Kidney Int 61(1 Suppl): S37-41 (2002)
2002  
82
New generation adenoviral vectors improve gene transfer by coxsackie and adenoviral receptor-independent cell entry.
[11841608] Kidney Int 61(1 Suppl): S24-31 (2002)
2002  
83
Recent advances in recombinant adeno-associated virus vector production.
[11841606] Kidney Int 61(1 Suppl): S9-15 (2002)
2002  
84
Herpes simplex virus as a model vector system for gene therapy in renal disease.
[11841605] Kidney Int 61(1 Suppl): S3-8 (2002)
1998  
85
Strategies of gene transfer to the kidney.
[9461084] Kidney Int 53(2): 264-72 (1998)
2005  
86
Tyrosine hydroxylase replacement in experimental Parkinson's disease with transvascular gene therapy.
[15717064] NeuroRx 2(1): 129-38 (2005)
2006  
87
Modeling chromosomes in mouse to explore the function of genes, genomic disorders, and chromosomal organization.
[16839184] PLoS Genet 2(7): e86 (2006)
2009  
88
Well-defined cationic shell crosslinked nanoparticles for efficient delivery of DNA or peptide nucleic acids.
[19687218] Proc Am Thorac Soc 6(5): 450-7 (2009)
2000  
89
Size does matter: overcoming the adeno-associated virus packaging limit.
[11667959] Respir Res 1(1): 16-8 (2000)
2006  
90
2006  
91
Ocular gene therapy: a review of nonviral strategies.
[17110916] Mol Vis 12(-): 1334-47 (2006)
2004  
92
2000  
93
Adeno-associated virus-based vectors in gene therapy.
[10895050] J Biomed Sci 7(4): 279-91 (2000)
2007  
94
Combating oncogene activation associated with retrovirus-mediated gene therapy of X-linked severe combined immunodeficiency.
[17464421] Braz J Med Biol Res 40(5): 601-13 (2007)
1998  
95
Gene therapy: a primer for radiologists.
[9821189] Radiographics 18(6): 1343-72 (1998)
1998  
96
2003  
97
Imaging of vascular gene therapy.
[12738874] Radiology 228(1): 36-49 (2003)
2008  
98
Physical approaches for nucleic acid delivery to liver.
[19083101] AAPS J 10(4): 589-95 (2008)
2007  
99
Vectors for airway gene delivery.
[17408235] AAPS J 9(1): E11-7 (2007)
2007  
100
Peptide-guided gene delivery.
[17408236] AAPS J 9(1): E18-29 (2007)
2009  
101
Learning from the viral journey: how to enter cells and how to overcome intracellular barriers to reach the nucleus.
[19194803] AAPS J 11(1): 65-77 (2009)
2005  
102
DNA-based therapeutics and DNA delivery systems: a comprehensive review.
[16146351] AAPS J 7(1): E61-77 (2005)
2009  
103
Nonviral gene delivery: principle, limitations, and recent progress.
[19834816] AAPS J 11(4): 671-81 (2009)
2009  
104
Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation.
[19132538] AAPS J 11(1): 23-30 (2009)
2010  
105
Nonviral gene transfer as a tool for studying transcription regulation of xenobiotic metabolizing enzymes.
[20713102] Adv Drug Deliv Rev 62(13): 1250-6 (2010)
2009  
106
Lentiviral delivery of short hairpin RNAs.
[19341774] Adv Drug Deliv Rev 61(9): 732-45 (2009)
2009  
107
Antioxidant enzyme gene transfer for ischemic diseases.
[19233238] Adv Drug Deliv Rev 61(4): 351-63 (2009)
2009  
108
Transcriptional targeting of tumor endothelial cells for gene therapy.
[19393703] Adv Drug Deliv Rev 61(7-8): 542-53 (2009)
2008  
109
Multilayered polyelectrolyte assemblies as platforms for the delivery of DNA and other nucleic acid-based therapeutics.
[18395291] Adv Drug Deliv Rev 60(9): 979-99 (2008)
2003  
110
Fratricidal retroviruses: a new twist in gene therapy.
[12673128] Cancer Biol Ther 2(1): 100-2 (2003)
2007  
111
Radiation to control transgene expression in tumors.
[17611403] Cancer Biol Ther 6(7): 1005-12 (2007)
2005  
112
Achieving hypoxia-inducible gene expression in tumors.
[15846086] Cancer Biol Ther 4(4): 359-64 (2005)
2003  
113
Gene therapy for psychiatric disorders.
[12562564] Am J Psychiatry 160(2): 208-20 (2003)
2010  
114
Lentiviral vectors in gene therapy: their current status and future potential.
[20143172] Arch Immunol Ther Exp (Warsz) 58(2): 107-19 (2010)
2010  
115
The role of liver sinusoidal cells in hepatocyte-directed gene transfer.
[19948827] Am J Pathol 176(1): 14-21 (2010)
2003  
116
Primer on medical genomics. Part X: Gene therapy.
[14601696] Mayo Clin Proc 78(11): 1370-83 (2003)
2005  
117
Pulsed high-intensity focused ultrasound enhances systemic administration of naked DNA in squamous cell carcinoma model: initial experience.
[15798154] Radiology 235(2): 541-6 (2005)
2006  
118
Delivery systems for the direct application of siRNAs to induce RNA interference (RNAi) in vivo.
[17057369] J Biomed Biotechnol 2006(4): 71659 (2006)
2010  
119
Exon skipping with morpholino oligomers: new treatment option for cardiomyopathy in Duchenne muscular dystrophy?
[20008475] Cardiovasc Res 85(3): 409-10 (2010)
2009  
120
Emerging potential of transposons for gene therapy and generation of induced pluripotent stem cells.
[19471016] Blood 114(8): 1461-8 (2009)
2010  
121
Gene therapy for vision loss -- recent developments.
[21122474] Discov Med 10(54): 425-33 (2010)
2009  
122
Viral vectors: from virology to transgene expression.
[18776913] Br J Pharmacol 157(2): 153-65 (2009)
2009  
123
Physical methods of nucleic acid transfer: general concepts and applications.
[19154421] Br J Pharmacol 157(2): 207-19 (2009)
2003  
124
Targeted genetic repair: an emerging approach to genetic therapy.
[12897195] J Clin Invest 112(3): 310-1 (2003)
2003  
125
Ribozyme-mediated revision of RNA and DNA.
[12897196] J Clin Invest 112(3): 312-8 (2003)
2003  
126
Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicing.
[12925685] J Clin Invest 112(4): 474-80 (2003)
2003  
127
The potential for gene repair via triple helix formation.
[12925687] J Clin Invest 112(4): 487-94 (2003)
2007  
128
Meganuclease and transposon mediated transgenesis in medaka.
[18047687] Genome Biol 8 Suppl 1(-): S10 (2007)
2007  
129
Manipulating the Xenopus genome with transposable elements.
[18047688] Genome Biol 8 Suppl 1(-): S11 (2007)
2007  
130
Predicting preferential DNA vector insertion sites: implications for functional genomics and gene therapy.
[18047689] Genome Biol 8 Suppl 1(-): S12 (2007)
2007  
131
Pigs taking wing with transposons and recombinases.
[18047690] Genome Biol 8 Suppl 1(-): S13 (2007)
2004  
132
Lentiviral transgene vectors.
[14710182] EMBO Rep 5(1): 28-9 (2004)
2007  
133
Toward reprogramming bacteria with small molecules and RNA.
[17967431] Curr Opin Chem Biol 11(6): 612-9 (2007)
2011  
134
Gammaretroviral vectors: biology, technology and application.
[21994751] Viruses 3(6): 677-713 (2011)
2011  
135
The inside out of lentiviral vectors.
[22049307] Viruses 3(2): 132-59 (2011)
2011  
136
Retroviral vectors: post entry events and genomic alterations.
[21994741] Viruses 3(5): 429-55 (2011)
2010  
137
Serotype chimeric human adenoviruses for cancer gene therapy.
[21994616] Viruses 2(10): 2196-212 (2010)
2010  
138
Development of viral vectors for use in cardiovascular gene therapy.
[21994642] Viruses 2(2): 334-71 (2010)
2010  
139
PEGylated Adenoviruses: From Mice to Monkeys.
[21994645] Viruses 2(2): 468-502 (2010)
2008  
140
Gene therapy using adeno-associated virus vectors.
[18854481] Clin Microbiol Rev 21(4): 583-93 (2008)
2003  
141
Harnessing apoptosis for improved anticancer gene therapy.
[14695163] Cancer Res 63(24): 8563-72 (2003)
2004  
142
Gene therapy in clinical medicine.
[15466989] Postgrad Med J 80(948): 560-70 (2004)
2004  
143
Lentiviral vectors for the central nervous system.
[15520640] MedGenMed 6(3): 17 (2004)
2010  
144
Transfection techniques for neuronal cells.
[20445041] J Neurosci 30(18): 6171-7 (2010)
2011  
145
Application of magnetic nanoparticles to gene delivery.
[21747701] Int J Mol Sci 12(6): 3705-22 (2011)
2008  
146
Recent developments in peptide-based nucleic acid delivery.
[19325804] Int J Mol Sci 9(7): 1276-320 (2008)
2009  
147
RNAi nanoparticles in the service of personalized medicine.
[19958219] Nanomedicine (Lond) 4(8): 853-5 (2009)
2010  
148
Cellular endocytosis and gene delivery.
[20454523] Mol Med 16(5-6): 222-9 (2010)
2010  
149
Single cell optical transfection.
[20064901] J R Soc Interface 7(47): 863-71 (2010)
2011  
150
The challenge for gene therapy: innate immune response to adenoviruses.
[21399236] Oncotarget 2(3): 113-21 (2011)
2010  
151
Delivering the code: polyplex carriers for deoxyribonucleic acid and ribonucleic acid interference therapies.
[20032060] Endocrinology 151(2): 466-73 (2010)
2011  
152
Novel approaches to in vitro transgenesis.
[21134989] J Endocrinol 208(3): 193-206 (2011)
2011  
153
The potential of virus-based gene therapies for treatment of metastatic kidney cancer.
[21707273] Expert Rev Anticancer Ther 11(6): 809-11 (2011)
2007  
154
The state of the art of adeno-associated virus-based vectors in gene therapy.
[17939872] Virol J 4(-): 99 (2007)
2010  
155
RNA-targeted splice-correction therapy for neuromuscular disease.
[20150322] Brain 133(Pt 4): 957-72 (2010)
2003  
156
Generating and manipulating transgenic animals using transposable elements.
[14613544] Reprod Biol Endocrinol 1(-): 80 (2003)
2003  
157
Specific genetic modifications of domestic animals by gene targeting and animal cloning.
[14614774] Reprod Biol Endocrinol 1(-): 103 (2003)
2007  
158
Live and let die: in vivo selection of gene-modified hematopoietic stem cells via MGMT-mediated chemoprotection.
[17482893] DNA Repair (Amst) 6(8): 1210-21 (2007)
2007  
159
Vector design for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.
[17482894] DNA Repair (Amst) 6(8): 1187-96 (2007)
2011  
160
Innate Immune Responses to AAV Vectors.
[21954398] Front Microbiol 2(-): 194 (2011)
2011  
161
Immunity and AAV-Mediated Gene Therapy for Muscular Dystrophies in Large Animal Models and Human Trials.
[21980317] Front Microbiol 2(-): 201 (2011)
2011  
162
Hydrodynamic gene delivery and its applications in pharmaceutical research.
[21191634] Pharm Res 28(4): 694-701 (2011)
2011  
163
Barriers to non-viral vector-mediated gene delivery in the nervous system.
[21225319] Pharm Res 28(8): 1843-58 (2011)
2010  
164
Pseudovirions as vehicles for the delivery of siRNA.
[19998056] Pharm Res 27(3): 400-20 (2010)
2007  
165
2008  
166
Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer.
[17763830] Pharm Res 25(3): 489-99 (2008)
2008  
167
Nonviral approaches for neuronal delivery of nucleic acids.
[17932730] Pharm Res 25(5): 983-98 (2008)
2007  
168
2011  
169
Perinatal gene transfer to the liver.
[21774770] Curr Pharm Des 17(24): 2528-41 (2011)
2010  
170
Development of non-viral vector for cancer gene therapy.
[20606371] Yakugaku Zasshi 130(7): 917-23 (2010)
2010  
171
Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS.
[19840853] Pharmacol Res 61(1): 14-26 (2010)
2008  
172
Development and evaluation of a novel gene delivery vehicle composed of adenovirus serotype 35.
[18827334] Biol Pharm Bull 31(10): 1819-25 (2008)
2004  
173
Recent advances in liver-directed gene transfer vectors.
[15313663] Hepatobiliary Pancreat Dis Int 3(3): 332-6 (2004)
2002  
174
Development of gene therapy for hematopoietic stem cells using lentiviral vectors.
[11960333] Leukemia 16(4): 563-9 (2002)
2010  
175
Nanoparticle-mediated interleukin-12 cancer gene therapy.
[21092717] J Pharm Pharm Sci 13(3): 472-85 (2010)
2011  
176
Integrin targeted delivery of gene therapeutics.
[21547161] Theranostics 1(-): 211-9 (2011)
2010  
177
Electrostatic surface modifications to improve gene delivery.
[20201712] Expert Opin Drug Deliv 7(4): 535-50 (2010)
2009  
178
Gene therapy in thalassemia and hemoglobinopathies.
[21415990] Mediterr J Hematol Infect Dis 1(1): e2009008 (2009)
2009  
179
Nonviral methods for siRNA delivery.
[19115957] Mol Pharm 6(3): 651-8 (2009)
2009  
180
Biological barriers to therapy with antisense and siRNA oligonucleotides.
[19397332] Mol Pharm 6(3): 686-95 (2009)
2010  
181
Nano-vectors for the Ocular Delivery of Nucleic Acid-based Therapeutics.
[21969738] Indian J Pharm Sci 72(6): 675-88 (2010)
2010  
182
Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells).
[19830583] Cell Biol Toxicol 26(1): 1-20 (2010)
2009  
183
Versatile somatic gene transfer for modeling neurodegenerative diseases.
[19669852] Neurotox Res 16(3): 329-42 (2009)
2005  
184
RNA nanotechnology: engineering, assembly and applications in detection, gene delivery and therapy.
[16430131] J Nanosci Nanotechnol 5(12): 1964-82 (2005)
2011  
185
Polymers in small-interfering RNA delivery.
[21749290] Nucleic Acid Ther 21(3): 133-47 (2011)
2011  
186
Development of viral vectors for gene therapy for chronic pain.
[22110937] Pain Res Treat 2011(-): 968218 (2011)
2008  
187
Transgenesis procedures in Xenopus.
[18699776] Biol Cell 100(9): 503-21 (2008)
2010  
188
Progress and prospects: immune responses to viral vectors.
[19907498] Gene Ther 17(3): 295-304 (2010)
2008  
189
Viral vectors for in vivo gene transfer in Parkinson's disease: properties and clinical grade production.
[17916354] Exp Neurol 209(1): 58-71 (2008)
2010  
190
Nanoparticles for retinal gene therapy.
[20452457] Prog Retin Eye Res 29(5): 376-97 (2010)
2010  
191
2011  
192
Advancements in adeno-associated viral gene therapy approaches: exploring a new horizon.
[21941595] F1000 Med Rep 3(-): 17 (2011)
2007  
193
Exploring cell type-specific internalizing antibodies for targeted delivery of siRNA.
[17670766] Brief Funct Genomic Proteomic 6(2): 112-9 (2007)
2010  
194
Update on gene therapy for immunodeficiencies.
[20071242] Clin Immunol 135(2): 247-54 (2010)
2010  
195
2010  
196
Recognition of virus infection and innate host responses to viral gene therapy vectors.
[20551916] Mol Ther 18(8): 1422-9 (2010)
2009  
197
Orthopedic gene therapy in 2008.
[19066598] Mol Ther 17(2): 231-44 (2009)
2010  
198
A transposon and transposase system for human application.
[20104209] Mol Ther 18(4): 674-83 (2010)
2010  
199
Recent advances in lentiviral vector development and applications.
[20087315] Mol Ther 18(3): 477-90 (2010)
2009  
200
Biological gene delivery vehicles: beyond viral vectors.
[19277019] Mol Ther 17(5): 767-77 (2009)
2009  
201
MicroRNAs and the regulation of vector tropism.
[19107117] Mol Ther 17(3): 409-16 (2009)
2009  
202
Progress in genetic therapy for severe combined immunodeficiency associated with adenosine deaminase deficiency.
[19337228] Mol Ther 17(4): 577-8 (2009)
2009  
203
Integration-deficient lentiviral vectors: a slow coming of age.
[19491821] Mol Ther 17(8): 1316-32 (2009)
2009  
204
New insights on adenovirus as vaccine vectors.
[19513019] Mol Ther 17(8): 1333-9 (2009)
2002  
205
Gene repair and transposon-mediated gene therapy.
[11897868] Stem Cells 20(2): 105-18 (2002)
2010  
206
Cell and gene therapies: moving from research to clinic.
[20350323] J Transl Med 8(-): 31 (2010)
2008  
207
Development of lentiviral gene therapy for Wiskott Aldrich syndrome.
[18194074] Expert Opin Biol Ther 8(2): 181-90 (2008)
2009  
208
Foamy virus vectors for gene transfer.
[19743892] Expert Opin Biol Ther 9(11): 1427-36 (2009)
2003  
209
Transcriptionally targeted gene therapy to detect and treat cancer.
[14557054] Trends Mol Med 9(10): 421-9 (2003)
2011  
210
Current advances in retroviral gene therapy.
[21453283] Curr Gene Ther 11(3): 218-28 (2011)
2011  
211
Gene therapy and targeted toxins for glioma.
[21453286] Curr Gene Ther 11(3): 155-80 (2011)
2009  
212
Immunomodulatory gene therapy in lysosomal storage disorders.
[19807648] Curr Gene Ther 9(6): 503-10 (2009)
2007  
213
Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions.
[17979681] Curr Gene Ther 7(5): 347-60 (2007)
2007  
214
Gene therapy for type I glycogen storage diseases.
[17430128] Curr Gene Ther 7(2): 79-88 (2007)
2006  
215
Regulatable gene expression systems for gene therapy.
[16918333] Curr Gene Ther 6(4): 421-38 (2006)
2010  
216
Lentiviral vectors for immune cells targeting.
[20085508] Immunopharmacol Immunotoxicol 32(2): 208-18 (2010)
2007  
217
Lentiviral vectors: are they the future of animal transgenesis?
[17684037] Physiol Genomics 31(2): 159-73 (2007)
2010  
218
Cardiac gene therapy: optimization of gene delivery techniques in vivo.
[19947886] Hum Gene Ther 21(4): 371-80 (2010)
2009  
219
Immune responses to herpesviral vectors.
[19216681] Hum Gene Ther 20(5): 434-41 (2009)
2009  
220
Large-scale adeno-associated viral vector production using a herpesvirus-based system enables manufacturing for clinical studies.
[19569968] Hum Gene Ther 20(8): 796-806 (2009)
2009  
221
Producing recombinant adeno-associated virus in foster cells: overcoming production limitations using a baculovirus-insect cell expression strategy.
[19604040] Hum Gene Ther 20(8): 807-17 (2009)
2008  
222
Molecular engineering of viral gene delivery vehicles.
[18647114] Annu Rev Biomed Eng 10(-): 169-94 (2008)
2003  
223
Current status of gene therapy for inherited lung diseases.
[12524461] Annu Rev Physiol 65(-): 585-612 (2003)
2009  
224
Methods, potentials, and limitations of gene delivery to regenerate central nervous system cells.
[19707413] Biologics 3(-): 245-56 (2009)
2011  
225
Research progress on siRNA delivery with nonviral carriers.
[21720513] Int J Nanomedicine 6(-): 1017-25 (2011)
2009  
226
Transposon-mediated genome manipulation in vertebrates.
[19478801] Nat Methods 6(6): 415-22 (2009)
2002  
227
Using nuclear targeting signals to enhance non-viral gene transfer.
[11940112] Immunol Cell Biol 80(2): 119-30 (2002)
2008  
228
Nonviral gene transfection nanoparticles: function and applications in the brain.
[18313990] Nanomedicine 4(2): 89-97 (2008)
2010  
229
Direct gene therapy for bone regeneration: gene delivery, animal models, and outcome measures.
[20143927] Tissue Eng Part B Rev 16(1): 13-20 (2010)
2009  
230
Adeno-associated virus vector integration.
[19649989] Curr Opin Mol Ther 11(4): 442-7 (2009)
2008  
231
Nonviral ocular gene therapy: assessment and future directions.
[18830921] Curr Opin Mol Ther 10(5): 456-63 (2008)
2007  
232
Bioconjugation of oligonucleotides for treating liver fibrosis.
[18154454] Oligonucleotides 17(4): 349-404 (2007)
2010  
233
Development of recombinant cationic polymers for gene therapy research.
[20399239] Adv Drug Deliv Rev 62(15): 1524-9 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.



  • Gentransfer

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia